Elsevier

Archives of Gerontology and Geriatrics

Volume 57, Issue 3, November–December 2013, Pages 360-368
Archives of Gerontology and Geriatrics

The ability of three different models of frailty to predict all-cause mortality: Results from the European Male Aging Study (EMAS)

https://doi.org/10.1016/j.archger.2013.06.010Get rights and content

Abstract

Few studies have directly compared the ability of the most commonly used models of frailty to predict mortality among community-dwelling individuals. Here, we used a frailty index (FI), frailty phenotype (FP), and FRAIL scale (FS) to predict mortality in the EMAS. Participants were aged 40–79 years (n = 2929) at baseline and 6.6% (n = 193) died over a median 4.3 years of follow-up. The FI was generated from 39 deficits, including self-reported health, morbidities, functional performance and psychological assessments. The FP and FS consisted of five phenotypic criteria and both categorized individuals as robust when they had 0 criteria, prefrail as 1–2 criteria and frail as 3+ criteria. The mean FI increased linearly with age (r2 = 0.21) and in Cox regression models adjusted for age, center, smoking and partner status the hazard ratio (HR) for death for each unit increase of the FI was 1.49. Men who were prefrail or frail by either the FP or FS definitions, had a significantly increased risk of death compared to their robust counterparts. Compared to robust men, those who were FP frail at baseline had a HR for death of 3.84, while those who were FS frail had a HR of 3.87. All three frailty models significantly predicted future mortality among community-dwelling, middle-aged and older European men after adjusting for potential confounders. Our data suggest that the choice of frailty model may not be of paramount importance when predicting future risk of death, enabling flexibility in the approach used.

Introduction

Although specific definitions and models of frailty remain contested there is broad agreement that it describes a non-specific state reflecting age-related declines in multiple physiological systems, which in turn lead to an increased risk of adverse outcomes including morbidity, hospitalization, institutionalization and mortality (Rockwood, Mitnitski, Song, Steen, & Skoog, 2006). Frailty may be conceptualized as a state characterizing the broad health of individuals, facilitating risk classification across a wide range of people and conditions (Rockwood & Mitnitski, 2007). While this implies that frailty need not be operationalized as a clinical syndrome, extensive research has focused on identifying those older people with and without a frailty syndrome, defined in terms of specific criteria such as exhaustion, slowness, low or decreased activity, weakness and unintentional weight loss (Fried et al., 2001, Kuh and New Dynamics of Ageing Preparatory, 2007). An alternative approach has been to construct an index of frailty by summing the number of accumulated age-related symptoms or deficits a person has to derive a score to predict future risk of adverse outcomes (Rockwood & Mitnitski, 2007).

Currently, the most commonly used approaches to characterize frailty include the FI of Rockwood and colleagues (Mitnitski et al., 2005, Rockwood and Mitnitski, 2007), the FP described by Fried and colleagues (Fried et al., 2001), and the FS proposed by the International Academy of Nutrition, Health and Aging (IANA) (Abellan van Kan et al., 2008a, Abellan van Kan et al., 2008b), but its utility has not been fully explored. The phenotypic approach has the advantage of being relatively simple to administer, although the relatively restrictive set of criteria may not be applicable to all individuals. Conversely, while frailty indices may offer a broader coverage of deficits than simpler models and also allow identification of high functioning individuals, they are more time consuming in terms of data collection and may be less practical to apply in a clinical setting.

Although index based and phenotypic definitions of frailty have proved useful in predicting a range of deleterious health outcomes (Sternberg, Wershof Schwartz, Karunananthan, Bergman, & Mark Clarfield, 2011), there are few data describing how well the most commonly used frailty models predict mortality in older men living in different regions of the European Union. In this study we utilized the cohort of men participating in the European Male Aging Study to examine and compare the utility of three frailty models adapted from existing index and phenotypic approaches to predict all-cause mortality. A secondary aim was to investigate which of the individual component criteria of our frailty models were associated with mortality.

Section snippets

Participants and study design

Details concerning the study design and recruitment for the EMAS have been described previously (Lee et al., 2009). Briefly, an age-stratified probability sample of 3369 men aged 40–79 (mean ± SD: 60 ± 11) years were recruited from population registers in eight European centers (Florence, Italy; Leuven, Belgium; Malmö, Sweden; Manchester, UK; Santiago de Compostela, Spain; Łódź, Poland; Szeged, Hungary; Tartu, Estonia). Participants completed a postal questionnaire and then attended a research

Results

From the initial 3369 participants at baseline 106 could not take part in the follow-up assessment due to being institutionalized or were too frail, while 334 did not reply to the follow-up postal questionnaire, resulting in a total of 440 men lost to follow-up. During a median of 4.3 years of follow-up (range 3.0–5.7), comprising of 11,980 person-years, there were 193 deaths; an overall mortality rate of 6.6%. The characteristics of the 2929 men in the final analysis sample are shown in Table 1

Discussion

In this study we examined how three different models of frailty predicted all-cause mortality in a population-based sample of middle-aged and older European men. We found that increasing levels of frailty, as assessed by adaptations of all three commonly used models, were associated with a significantly increased risk of subsequent mortality. In multivariable adjusted Cox regression models each unitary increase (0.1 unit) in baseline FI (within the range 0–0.68) was associated with a 1.5 fold

Conflict of interest statement

None to declare.

Acknowledgements

The European Male Aging Study is funded by the Commission of the European Communities Fifth Framework Program “Quality of Life and Management of Living Resources” Grant QLK6-CT-2001-00258. Non-financial support was also provided by Arthritis Research UK and the National Institute for Health Research Manchester Biomedical Research Center. The authors wish to thank the men who participated, the research/nursing staff in the eight centers: C. Pott (Manchester), E. Wouters (Leuven), M. Nilsson

References (42)

  • K. Bandeen-Roche et al.

    Phenotype of frailty: Characterization in the women's health and aging studies

    Journals of Gerontology, Series A: Biological Sciences and Medical Sciences

    (2006)
  • A.T. Beck et al.

    Manual for the Beck Depression Inventory-II

    (1996)
  • J.L. Bosch et al.

    The International Prostate Symptom Score in a community-based sample of men between 55 and 74 years of age: Prevalence and correlation of symptoms with age, prostate volume, flow rate and residual urine volume

    British Journal of Urology

    (1995)
  • P.M. Cawthon et al.

    Frailty in older men: Prevalence, progression, and relationship with mortality

    Journal of the American Geriatrics Society

    (2007)
  • L.P. Fried et al.

    Frailty in older adults: Evidence for a phenotype

    Journals of Gerontology, Series A: Biological Sciences and Medical Sciences

    (2001)
  • W.B. Goggins et al.

    Frailty index as a measure of biological age in a Chinese population

    Journals of Gerontology, Series A: Biological Sciences and Medical Sciences

    (2005)
  • J.E. Graham et al.

    Frailty and 10-year mortality in community-living Mexican American older adults

    Gerontology

    (2009)
  • D. Kuh et al.

    A life course approach to healthy aging, frailty, and capability

    Journals of Gerontology, Series A: Biological Sciences and Medical Sciences

    (2007)
  • D.M. Lee et al.

    The European Male Ageing Study (EMAS): Design, methods and recruitment

    International Journal of Andrology

    (2009)
  • D.M. Lee et al.

    Cohort profile: The European Male Ageing Study

    International Journal of Epidemiology

    (2013)
  • D.M. Lee et al.

    Frailty and sexual health in older European men

    Journals of Gerontology, Series A: Biological Sciences and Medical Sciences

    (2013)
  • Cited by (117)

    • Frailty: Past, present, and future?

      2021, Sports Medicine and Health Science
    • CAUSES, mortality rates and risk factors of death in community-dwelling Europeans aged 50 years and over: Results from the Survey of Health, Ageing and Retirement in Europe 2013–2015

      2020, Archives of Gerontology and Geriatrics
      Citation Excerpt :

      Self-rated health was found to be an independent predictor of mortality (Falk et al., 2017; Szybalska et al., 2018), and showed a similar predictive power when objective health measures were used (Lima-Costa, Cesar, Chor, & Proietti, 2012). Greater frailty (Garre-Olmo, Calvó-Perxas, López-Pousa, de Gracia Blanco, & Vilalta-Franch, 2013; Ravindrarajah et al., 2013), and deficits in Activities of Daily Living (ADL) were associated with higher mortality risk (Formiga et al., 2016; Nascimento, Oliveira, Firmo, Lima-Costa, & Peixoto, 2018). Finally, higher comorbidity (Gagne, Glynn, Avorn, Levin, & Schneeweiss, 2011; Nunes, Flores, Mielke, Thumé, & Facchini, 2016) and the accumulation of geriatric syndromes (Huang et al., 2017) were relevant risk factors.

    View all citing articles on Scopus
    1

    Joint first-authorship.

    2

    The European Male Aging Study Group: Florence (Gianni Forti, Luisa Petrone, Giovanni Corona); Leuven (Dirk Vanderschueren, Steven Boonen, Herman Borghs); Łódź (Krzysztof Kula, Jolanta Slowikowska-Hilczer, Renata Walczak-Jedrzejowska); London (Ilpo Huhtaniemi); Malmö (Aleksander Giwercman); Manchester (Frederick Wu, Neil Pendleton, Terence O’Neill, Joseph Finn, Philip Steer, David Lee, Stephen Pye); Santiago (Felipe Casanueva, Ana I Castro); Szeged (Gyorgy Bartfai, Imre Földesi, Imre Fejes); Tartu (Margus Punab, Paul Korrovitz); Turku (Min Jiang).

    View full text